Gene Query: GLRX3

Dataset Description Geneva Score
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 34.31
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 34.31
Co-transcriptional loading of RNA export factors shapes the human transcriptome 27.26
RNAseq of HEK293 cells after Chtop knockdown 27.26
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 26.92
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 23.71
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 19.71
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 18.48
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 17.8
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 17.63
Altering cancer transcriptomes using epigenomic inhibitors 17.63
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 16.59
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 16.12
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 16.04
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 16.03
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 16.03
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 15.94
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 14.79
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 14.45
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 14.2
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 14.11
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 13.99
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 13.99
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 13.1
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 12.95
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 12.95
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 12.94
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 12.72
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 12.38
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 12.16
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 11.95
Nrf2 regulated genes in A549 cells 11.88
Identification of Nrf2 regulated genes by RNA sequencing 11.88
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 11.7
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 11.69
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 11.6
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 11.44
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 11.44
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 11.18
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 10.96
Differential expression of genes in AD169-infected MRC5. 10.95
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 10.89
3’ Uridylation Expands miRNA Target Repertoire 10.83
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 10.81
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 10.81
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 10.77
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 10.64
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 10.53
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 10.49
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 10.49
RNA-seq of human aneuploid cell lines with Trisomy 21 10.41
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 10.4
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 10.31
An acquired vulnerability of drug resistant melanoma with therapeutic potential 10.31
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 10.27
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 10.18
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 10.12
K562 polyA RNA-Seq 10.08
A transcriptome-wide divergence in protein translation scales with LIN28B expression 10.06
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 10.0
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 9.99
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 9.97
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 9.88
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 9.88
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 9.79
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 9.72
Transcriptome analysis of U87 cells upon LINC00152 knockdown 9.67
Identification of Sin3B regulated genes during quiescence 9.66
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 9.66
AR-independent prostate cancer is sustained through FGF signaling 9.65
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 9.54
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 9.44
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 9.43
Global analysis of enhancer targets: Mosaic-seq 9.42
Transcriptome of activated human and mouse MAIT cells 9.4
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 9.27
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 9.27
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 9.27
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 9.25
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 9.25
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 9.2
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 9.14
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 9.13
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 9.12
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 9.12
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 9.11
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 9.04
CROP-Seq in Primary Human T Cells 9.01
ARID1A regulates condensin II distribution and chromosomal partition 8.95
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 8.95
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 8.88
Identification of transcription start sites for human A549 cell line using ReCappable-seq 8.87
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 8.82
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 8.82
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 8.71
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 8.71
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 8.62
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 8.58
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 8.57
RNA-seq analysis to identify the genes regulated by p53-SET interplay 8.55
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 8.52
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 8.52
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 8.49
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 8.46
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 8.41
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 8.41
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 8.38
Effect of FGF13 depletion on the H460 cell line 8.38
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 8.29
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 8.29
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 8.29
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 8.28
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 8.27
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 8.26
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 8.17
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 8.13
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 8.12
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 8.09
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 8.08
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 8.05
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 7.97
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 7.97
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 7.97
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 7.97
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 7.92
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 7.88
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 7.84
The human blood-nerve barrier transcriptome 7.82
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 7.79
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 7.79
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 7.79
Effect of PRDM11 depletion in U2932 cells 7.78
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 7.77
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 7.77
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 7.7
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 7.69
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 7.68
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 7.58
Global analysis of alternative splicing regulated by RBM10 7.58
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 7.52
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 7.51
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 7.51
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 7.42
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 7.42
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 7.41
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 7.41
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 7.36
The landscape of alternative splicing in aggressive prostate cancers 7.36
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 7.31
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 7.28
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 7.27
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 7.26
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 7.24
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 7.22
Single-nucleotide-resolution mapping of HBV promoters using CAGE 7.22
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 7.2
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 7.2
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 7.2
ARID1A and ARID1B loss in HCT116 and TOV21G cells 7.2
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 7.17
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 7.16
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 7.16
RNA-seq of resting and activated CD4+ T cells +-JQ1 7.14
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 7.09
Expression level comparison under dividing and quiescent states in human primary fibroblasts 7.03
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 7.02
RNA-seq of RKO cells with cTAZ KO or putback 6.98
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 6.94
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 6.94
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 6.9
Identification of long noncoding RNAs regulated by p53 6.89
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 6.85
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 6.84
SOX11 knockdown in B-ALL cell lines 6.83
METTL3 and WTAP 6.71
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 6.71
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 6.67
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 6.66
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 6.64
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 6.64
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 6.61
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 6.58
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 6.57
Transcriptome sequencing of K-562 cells 6.57
Identification of HOXB13 target genes responsive to BET inhibitors 6.54
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 6.53
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 6.51
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 6.5
Landscape and variation of RNA secondary structure across the human transcriptome 6.4
mRNA expression profile of Lymphocytes 6.38
SRSF1 role in cellular gene expression and splicing 6.37
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 6.36
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 6.36
Systematic discovery of endogenous human ribonucleoprotein complexes 6.31
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 6.3
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 6.28
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 6.24
Gene expression changes in human melanoma cell lines compared to primary melanocytes 6.22
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 6.21
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 6.17
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 6.17
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 6.17
Gene expression analysis of human liver progenitor-like cells in culture 6.12
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 6.11
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 6.04
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 6.0
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 5.99
Tracking distinct RNA populations using efficient and reversible covalent chemistry 5.98
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 5.96
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 5.95
MEIS1 regulates hematopoiesis in hPSCs 5.91
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 5.91
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 5.88
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 5.88
Transcriptomic analysis of the HOTAIR-regulated genes 5.82
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 5.82
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 5.8
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 5.78
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 5.77
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 5.77
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 5.77
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 5.71
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 5.71
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 5.65
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 5.59
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 5.57
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 5.56
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 5.53
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 5.52
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 5.52
RNA seq comparison between scrambled and shGRP78 cells 5.52
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 5.51
SLIGRL-induced gene expression changes in NHEK cells 5.46
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 5.46
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 5.46
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 5.43
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 5.43
Transcription control by the ENL YEATS domain in acute leukemia 5.43
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 5.43
Solid phase chemistry to covalently and reversibly capture thiolated RNA 5.43
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 5.41
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 5.41
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 5.4
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 5.4
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 5.4
Unique features and clinical importance of acute alloreactive immune responses 5.35
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 5.34
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 5.32
Transcriptome landscape of HeLa response upon triamcinolone acetonide 5.29
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 5.24
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 5.24
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 5.24
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 5.24
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 5.13
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 5.13
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 5.1
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 5.09
Transcriptome analysis upon C6orf203 silencing 5.09
MCF-7 as a model for functional analysis of breast cancer risk variants 5.05
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 4.99
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 4.99
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 4.96
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 4.95
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  4.95
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 4.94
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 4.93
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 4.88
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 4.86
Effect of PBK knockdown on C4-2 cell transcriptome 4.85
scRNASeq analysis of cycling cardiomyocytes 4.82
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 4.74
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 4.74
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 4.73
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 4.65
Chromatin landscape of human visceral and subcutaneous adipocytes 4.65
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 4.64
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 4.61
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 4.58
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 4.54
Selective expression of long non-coding RNAs in a breast cancer cell progression model 4.52
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 4.5
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 4.49
Generation of trichogenic adipose-derived stem cells by expression of three factors 4.47
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 4.46
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 4.42
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 4.42
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 4.32
Aneuploidy-induced cellular stresses limit autophagic degradation. 4.31
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 4.3
Ribosome profiling upon inhibition of eIF4A 4.29
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 4.28
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 4.27
An integrative analysis of non-coding regulatory DNA variations associated with autism 4.22
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 4.21
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 4.21
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 4.21
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 4.21
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 4.19
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 4.11
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 4.11
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 4.09
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 4.09
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 4.02
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 4.02
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 3.86
Differential Protein Occupancy Profiling of the mRNA Transcriptome 3.83
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 3.83
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 3.81
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 3.81
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 3.71
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 3.71
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 3.67
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 3.62
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 3.6
Zone dependent distinctive gene expression profile of the normal human liver tissue 3.59
The Genetic Landscape of Diamond-Blackfan Anemia 3.56
Derivation and differentiation of haploid human embryonic stem cells 3.56
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 3.53
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 3.52
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 3.51
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 3.5
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 3.49
RNA sequencing of mechanically strained NHEKs and control NHEKs 3.49
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 3.46
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 3.46
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 3.45
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 3.44
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 3.42
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 3.42
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 3.38
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 3.38
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 3.34
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 3.31
RNA-Seq of PRMT1 overexpression ECA109 cells 3.3
Real-time observation of light-controlled transcription in living cells 3.3
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 3.26
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 3.25
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 3.15
Expression profiling of converted and control dermal BJ fibroblasts 3.13
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 3.13
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 3.13
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 3.11
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 3.11
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 3.11
An siRNA screen identifies CHD4 as a target for epigenetic therapy 3.08
A map of gene expression in neutrophil-like cell lines 3.05
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 3.01
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 3.01
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 2.98
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 2.96
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 2.94
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 2.92
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 2.89
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 2.83
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 2.76
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 2.72
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 2.71
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 2.7
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 2.7
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 2.63
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 2.62
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 2.59
NAPRT activation of macrophages 2.56
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 2.55
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 2.53
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 2.46
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 2.46
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 2.39
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 2.38
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 2.38
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 2.32
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 2.31
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 2.3
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 2.26
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 2.26
FOXP2's impact on the primate transcriptome 2.25
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 2.24
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 2.21
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 2.14
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 2.13
Functional significance of the HIV-1 Tat signature amino acid residues 2.11
single cell RNA-seq from GM12878 (ENCSR673UIY) 2.1
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 2.05
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 2.05
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 2.05
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 2.05
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 2.04
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 2.04
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 2.02
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 1.94
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 1.88
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 1.88
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 1.87
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 1.86
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.77
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 1.75
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 1.68
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 1.66
Generation and persistence of human tissue-resident memory T cells in lung transplantation 1.64
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 1.58
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 1.53
HBEC-shp53-PCHD7 1.53
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 1.52
Single-cell analysis of human kidney organoids 1.51
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.49
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 1.47
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 1.47
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 1.36
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 1.33
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.31
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 1.29
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 1.29
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 1.28
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 1.28
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 1.28
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 1.26
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 1.26
RNAseq of T-ALL upon long non coding rna purturbation 1.24
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 1.24
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.24
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 1.23
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 1.18
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 1.18
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.14
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 1.14
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 1.12
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 1.11
p63 controls the enhancer landscape during keratinocyte differentiation 1.11
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 1.1
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 1.1
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.09
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 1.05
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 1.05
Exogenous rescue of KLHL9 in SF210 cell line 1.04
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 1.03
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 0.99
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 0.99
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 0.97
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.95
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 0.94
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.87
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.81
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.81
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 0.79
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 0.79
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 0.79
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 0.68
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 0.68
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 0.67
Determining mRNA half-lives on a transcriptome-wide scale 0.64
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.62
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.6
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.59
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.59
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.58
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.57
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.54
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.52
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.52
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.5
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.5
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 0.5
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 0.45
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.42
EGR1-controlled transcriptome of T HESCs 0.38
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.38
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.36
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.36
Myc activation coordinates gene transcription and protein translation responses 0.36
Zika virus directly infects human peripheral neurons and induces cell death 0.32
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.3
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.3
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.3
Comparative Analysis of Cas9 Activators Across Multiple Species 0.27
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.25
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 0.25
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.24
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.24
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 0.21
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.21
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.21
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.2
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.2
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.19
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.18
Anti-inflammatory effect of indoleacrylic acid (IA) 0.17
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 0.16
Survival of pancreatic cancer cells lacking KRAS function 0.15
SF3B1 Degron knockdown RNA-seq 0.12
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.11
Discovering human diabetes-risk gene function with genetics and physiological assays 0.1
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.09
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 0.09
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 0.08
Transcriptional landscape changes during human embryonic stem cell derivation 0.05
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 0.04
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.03
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.0
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.0
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation